Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at BofA Securities
July 14, 2026 6:02 AM
BofA Securities analyst Tazeen Ahmad lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $410.00 (from $460.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
